XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Statement of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Balance at Beginning at Dec. 31, 2021 $ 93,073 $ 45 $ 134,933 $ (41,905) $ 0
Balance at Beginning (in Shares) at Dec. 31, 2021   54,181,082      
Issuance of common stock upon exercise of stock options 1,372 $ 1 1,371    
Issuance of common stock upon exercise of stock options, shares   1,097,860      
Share-based compensation expense 1,409   1,409    
Net loss (9,036)     (9,036)  
Balance at Ending at Mar. 31, 2022 86,818 $ 46 137,713 (50,941) 0
Balance at Ending (in Shares) at Mar. 31, 2022   55,278,942      
Balance at Beginning at Dec. 31, 2022 60,529 $ 55 145,221 (84,720) (27)
Balance at Beginning (in Shares) at Dec. 31, 2022   55,628,208      
Issuance of common stock upon exercise of stock options 352   352    
Issuance of common stock upon exercise of stock options, shares   125,890      
Issuance of common stock for vesting of restricted stock units   50,415      
Share-based compensation expense 2,692   2,692    
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $7.5 million 107,527 $ 6 107,521    
Issuance of common stock from initial public offering, net of issuance costs and underwriting discount of $7.5 million, shares   5,476,190      
Net loss (13,454)     (13,454)  
Unrealized loss on available-for-sale marketable securities (29)       (29)
Balance at Ending at Mar. 31, 2023 $ 157,617 $ 61 $ 255,786 $ (98,174) $ (56)
Balance at Ending (in Shares) at Mar. 31, 2023   61,280,703